These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2704870)

  • 21. Calcium channel blockers in systemic hypertension.
    Frishman WH; Charlap S; Michelson EL
    Am J Cardiol; 1986 Jul; 58(1):157-60. PubMed ID: 3524178
    [No Abstract]   [Full Text] [Related]  

  • 22. Case presentation. Initiation of gingival overgrowth by an increased daily dosage of nifedipine.
    Henderson JS; Guillot JL; Krolls SO; Parkel CO; Johnson RB
    Miss Dent Assoc J; 1994; 50(3):12-3. PubMed ID: 9569836
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nifedipine in ischemic heart disease.
    Kloner RA
    Circulation; 1995 Sep; 92(5):1074-8. PubMed ID: 7648647
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Open study to evaluate the efficacy and tolerance of prolonged-action nifedipine in the treatment of mild to moderate essential arterial hypertension].
    Med Clin (Barc); 1988 Oct; 91(13):493-5. PubMed ID: 3226200
    [No Abstract]   [Full Text] [Related]  

  • 27. Another report of adverse reactions to immediate-release nifedipine.
    Fami MJ; Ho NT; Mason CM
    Pharmacotherapy; 1998; 18(5):1133-5. PubMed ID: 9758326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
    Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
    Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bioequivalence of nifedipine sustained-release formulations in comparison to standard preparations in solid state].
    Herrmann R
    Arzneimittelforschung; 1996 Jan; 46(1):28-34. PubMed ID: 8821514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?
    Yusuf S
    Circulation; 1995 Sep; 92(5):1079-82. PubMed ID: 7648648
    [No Abstract]   [Full Text] [Related]  

  • 33. [Alterations in hepatitic metabolism induced by prolonged-action nifedipine in Mexican population].
    Palma-Aguirre JA; Campos-Lara M; Chávez-Negrete A
    Gac Med Mex; 2002; 138(4):381-3. PubMed ID: 12200885
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of a combination of a diuretic and nifedipine retard for the treatment of hypertensive patients refractory to nifedipine retard].
    Martínez López JJ; Rúiz López FJ; Gómez Márquez M; Ortega González G; Molina Boix M; Florenciano Sánchez R
    An Med Interna; 1993 Aug; 10(8):386-9. PubMed ID: 8218783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two formulations of nifedipine during 24-hour ambulatory blood pressure monitoring--a comment.
    Lucas BD; Hilleman DE; Wurdeman RL
    Pharmacotherapy; 1997; 17(4):853-4. PubMed ID: 9250574
    [No Abstract]   [Full Text] [Related]  

  • 36. Dose initiation of calcium antagonists in the treatment of hypertension.
    Müller FB; Erne P; Hotz M; Bolli P; Follath F; Bühler FR
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):118S-124S. PubMed ID: 3794763
    [No Abstract]   [Full Text] [Related]  

  • 37. Early side-effects of antihypertensive therapy: comparison of amlodipine and nifedipine retard.
    Bremner AD; Fell PJ; Hosie J; James IG; Saul PA; Taylor SH
    J Hum Hypertens; 1993 Feb; 7(1):79-81. PubMed ID: 8450526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced proteinuria after cessation of long-acting, osmotic release nifedipine GITS in diabetic nephropathy.
    Hess B
    Nephrol Dial Transplant; 1997 Aug; 12(8):1772-3. PubMed ID: 9269678
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of two formulations of nifedipine during 24-hour ambulatory blood pressure monitoring.
    Granberry MC; Gardner SF; Schneider EF; Carter IR
    Pharmacotherapy; 1996; 16(5):932-6. PubMed ID: 8888089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.